Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (111-120 of 740) with videos related to

Pageof 74
Sort By:
Oncotargets and Therapy|May 22, 2013
Pomalidomide: a novel drug to treat relapsed and refractory multiple myelomaEvangelos Terpos, Nikolaos Kanellias, Dimitrios Christoulas, et al.
Open Access Journal of Urology|November 8, 2013
Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysisAlexandra Karadimou, Evangelos Lianos, Dimitrios Pectasides, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Diagnosis and management of Waldenstrom's macroglobulinemiaMeletios A Dimopoulos, Robert A Kyle, Athanasios Anagnostopoulos, et al.
Leukemia Research|August 12, 2011
Response to bortezomib of a patient with scleromyxedema refractory to other therapiesMagdalini Migkou, Maria Gkotzamanidou, Evangelos Terpos, et al.
Haematologica|January 12, 2005
How we treat Waldenström's macroglobulinemiaMeletios A Dimopoulos, Giampaolo Merlini, Veronique Leblond, et al.
Journal of Medicinal Food|June 14, 2011
The mediterranean diet in cancer prevention: a reviewNiki Kontou, Theodora Psaltopoulou, Demosthenes Panagiotakos, et al.
Nature Reviews. Clinical Oncology|November 26, 2014
Current treatment landscape for relapsed and/or refractory multiple myelomaMeletios A Dimopoulos, Paul G Richardson, Philippe Moreau, et al.
Obstetrics and Gynecology International|June 15, 2013
Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agentsGiannis Mountzios, Aspasia Soultati, Dimitrios Pectasides, et al.
The Lancet. Oncology|June 15, 2016
Carfilozomib versus bortezomib for relapsed or refractory myeloma - Authors' replyMeletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, et al.
Leukemia & Lymphoma|April 15, 2003
High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrenceMeletios A Dimopoulos, Christos Papadimitriou, Athanassios Anagnostopoulos, et al.
Pageof 74

Showing results (111-120 of 740) with videos related to

Sort By:
Pageof 74
Oncotargets and Therapy|May 22, 2013
Pomalidomide: a novel drug to treat relapsed and refractory multiple myelomaEvangelos Terpos, Nikolaos Kanellias, Dimitrios Christoulas, et al.
Open Access Journal of Urology|November 8, 2013
Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysisAlexandra Karadimou, Evangelos Lianos, Dimitrios Pectasides, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Diagnosis and management of Waldenstrom's macroglobulinemiaMeletios A Dimopoulos, Robert A Kyle, Athanasios Anagnostopoulos, et al.
Leukemia Research|August 12, 2011
Response to bortezomib of a patient with scleromyxedema refractory to other therapiesMagdalini Migkou, Maria Gkotzamanidou, Evangelos Terpos, et al.
Haematologica|January 12, 2005
How we treat Waldenström's macroglobulinemiaMeletios A Dimopoulos, Giampaolo Merlini, Veronique Leblond, et al.
Journal of Medicinal Food|June 14, 2011
The mediterranean diet in cancer prevention: a reviewNiki Kontou, Theodora Psaltopoulou, Demosthenes Panagiotakos, et al.
Nature Reviews. Clinical Oncology|November 26, 2014
Current treatment landscape for relapsed and/or refractory multiple myelomaMeletios A Dimopoulos, Paul G Richardson, Philippe Moreau, et al.
Obstetrics and Gynecology International|June 15, 2013
Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agentsGiannis Mountzios, Aspasia Soultati, Dimitrios Pectasides, et al.
The Lancet. Oncology|June 15, 2016
Carfilozomib versus bortezomib for relapsed or refractory myeloma - Authors' replyMeletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, et al.
Leukemia & Lymphoma|April 15, 2003
High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrenceMeletios A Dimopoulos, Christos Papadimitriou, Athanassios Anagnostopoulos, et al.
Pageof 74